Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

USIM Selected as Media and The BAM Connection Awarded Creative for Zegerid OTC®


News provided by

USIM

Jul 25, 2023, 11:45 ET

Share this article

Share toX

Share this article

Share toX


USIM, the fastest growing, independent, modern media agency, and award-winning creative agency The BAM Connection, have been selected for Zegerid OTC®.

NEW YORK, July 25, 2023  /PRNewswire-PRWeb/ -- USIM, the fastest-growing independent, modern media agency, and award-winning creative agency, The BAM Connection, are proud to announce their selection as the Media and Creative for Zegerid OTC®.

This assignment reignites the USIM and The BAM Connection's powerful partnership in marketing OTC brands. USIM will handle strategic media planning and activation duties, while The BAM Connection will provide creative and social services to support Zegerid OTC® marketing initiatives.

"Having worked previously with USIM and The BAM Connection I knew the strength of their partnership in delivering data-informed, highly targeted, creative campaigns across the most actionable consumer touchpoints,” said Scott Chapman, Chief Executive Officer, Carlin Consumer Health.

Post this

"Having worked previously with USIM and The BAM Connection I knew the strength of their partnership in delivering data-informed, highly targeted, creative campaigns across the most actionable consumer touchpoints," said Scott Chapman, Chief Executive Officer, Carlin Consumer Health. "I'm looking forward to working with them in delivering exceptional campaigns and results for Zegerid OTC®."

"Zegerid OTC® is an iconic brand with a strong point of difference in a highly competitive category," said Chad Urice, Chief Strategic Officer, USIM. "We look forward to partnering with the brand in guiding consumers along their 'path to heartburn relief' that will drive increased engagement and sales." Maureen Maldari, Co-Founder and CEO of The BAM Connection added, "We have a world-class, fully integrated team that is poised to establish Zegerid OTC® as a significant player in the highly competitive antacid category."

About USIM
USIM is the fastest-growing, independent, modern media agency in the United States, providing our clients with solutions that surpass their business goals and outperform their competitors. Our mantra and mission, Forward, is at the heart of our success. Forward challenges the status quo and pushes the boundaries of technology and media. Forward anticipates the unpredictable, adapts rapidly to disruption, and flexes with the changes in consumer consumption, technology, and marketplace influences. Forward drives our culture of innovation, collaboration, and experimentation. And Forward fuels powerful results, unmatched client and employee retention, and industry accolades. For more information, please visit http://www.theusim.com.

About The BAM Connection
Founded in 2013 by New York ad agency leaders, Rob Baiocco and Maureen Maldari, The BAM Connection challenges the complexity of agency models with a tenacious belief that simplicity liberates Creativity. They believe that every brand deserves one pithy, compelling phrase that nails their brand's meaning and directs and connects all communication. They call it the One-Shot AnswerTM. Their experience and track record of building billion-dollar brands means they know how to cut through the process and get to the answers that make a difference, with their mantra "Success without the B.S.". The BAM Connection offers all the branding and digital content you need with one streamlined model that provides end-to-end brand connection. https://thebam.com/

About Carlin Consumer Health
Healthcare private equity firms Hildred Capital Management, LLC, Bourne Partners Strategic Capital, and The Emerson Group launched Carlin Consumer Health ("Carlin") in 2022 to establish a preeminent consumer health business. Our growth initiatives are focused on acquiring leading over-the-counter brands in the OTC market. Carlin's first acquisition (from Bayer AG) was the iconic Zegerid OTC®, a proton pump inhibitor used to treat frequent heartburn. And we are actively continuing to build our platform of strategically aligned brands that benefit from an operationally focused strategy and a collaborative approach to partnering with retailers to meet consumers' and their families' health and wellness needs. For more information, please visit http://www.carlinconsumerhealth.com.

Media Contact

benson hausman, USIM, 3478432193, bhausman@theusim.com

SOURCE USIM

Modal title

USIM Selected as Media and The BAM Connection Awarded Creative for Zegerid OTC®
View PDF
USIM Selected as Media and The BAM Connection Awarded Creative for Zegerid OTC®
USIM Selected as Media and The BAM Connection Awarded Creative for Zegerid OTC®

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.